
Merck | Home
At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Who we are - Merck.com
Merck aspires to be the premier research-intensive biopharmaceutical company in the world. Learn about our commitment to save and improve lives.
Research - Merck.com
At Merck, we follow the science. Learn about Merck's research and products by getting to know the science, strategy and brains behind the innovations.
History - Merck.com
Merck merged with Sharp & Dohme The merger brought together Merck's extensive chemical research and manufacturing facilities with Sharp & Dohme's pharmaceutical development, …
Company fact sheet - Merck.com
Dec 31, 2024 · Merck is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products. …
Pipeline - Merck.com
Apr 30, 2025 · Merck is working with Daiichi Sankyo to address FDA feedback. Oncology Previously treated locally advanced or metastatic EGFR-mutated NSCLC
Vaccines - Merck.com
Merck's work in vaccines focuses on making certain diseases a thing of the past. At Merck, we follow the science.
Clinical trials - Merck.com
There are Merck clinical trials in progress. Find a Merck trial. Medical advances can only happen through these scientific and voulnteer efforts.
Investor relations - Merck.com
May 30, 2025 · Merck’s (NYSE: MRK) Q3 2024 financial results represent strong progress across the business and our diverse pipeline. Our company announced worldwide sales of $16.7 …
Apr 1, 1978 · To report SUSPECTED ADVERSE REACTIONS, contact Merck Sharp & Dohme LLC at 1-877-888-4231 or VAERS at 1-800-822-7967 or www.vaers.hhs.gov .-----DRUG …